UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 
 
FORM 8-K 
 
 

 CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
 
Date of Report: (Date of earliest event reported): June 25, 2019
 
 
 
Calyxt, Inc.
(Exact name of registrant as specified in its charter)
 
 

 
 
         
Delaware
 
001-38161
 
27-1967997
(State or other jurisdiction
of incorporation)
 
(Commission
File Number)
 
(IRS Employer
Identification No.)
 

2800 Mount Ridge Road
Roseville, MN 55113-1127
(Address and zip code of principal executive offices)
 
(651) 683-2807 
(Registrant’s telephone number, including area code)
 
Not Applicable
(Former name or former address, if changed since last report)
 


 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) 
 
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) 
 
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) 
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
 
Emerging growth company
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each class
 
Trading Symbol(s)
 
Name of exchange on
which registered
Common Stock, par
value $0.0001 per share
 
CLXT
 
The NASDAQ Global
Market
 

Item 8.01.
Regulation FD Disclosure

On June 25, 2019, Calyxt, Inc. (the “Company”) issued a press release in connection with its Investor Day to be held at the Company’s headquarters on June 25, 2019, a copy of which is furnished as Exhibit 99.1 to this Current Report on Form 8-K.  Imbedded in the press release is a link to a presentation that will be presented by representatives of the Company at the Investor Day, a copy of which is furnished as Exhibit 99.2 to this Current Report on Form 8-K.   

The information in Item 8.01 of this Form 8-K (including Exhibit 99.1 and Exhibit 99.2) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference under the Securities Act of 1933, as amended, except as expressly set forth by specific reference in such a filing, regardless of any general incorporation language in any such filing, unless the Company expressly sets forth in such filing that such information is to be considered “filed” or incorporated by reference therein.
 
Item 9.01.
Financial Statements and Exhibits.
 
d. Exhibits
 

 Exhibit
Number
Description
   
99.1
Press Release of Calyxt, Inc. dated June 25, 2019
99.2
Calyxt, Inc. Investor Day Presentation dated June 25, 2019



SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, Calyxt, Inc. has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
Dated: June 25, 2019
 
  CALYXT, INC  
       

By:
/s/ James A. Blome  
  Name:
James A. Blome  
  Title:
Chief Executive Officer  



EXHIBIT INDEX
 

 Exhibit
Number
Description
   

Exhibit 99.1



Calyxt® Reiterates 2019 Guidance and Gives Business Update During June 25 Investor Day

MINNEAPOLIS-ST. PAUL, Minn.--(BUSINESS WIRE)--June 25, 2019--Calyxt, Inc. (NASDAQ:CLXT), a healthy food ingredients company, will host an Investor & Analyst Day at the Company’s headquarters on Tuesday, June 25, 2019. During the event, the Company will reiterate its 2019 financial guidance and give a business update covering the following points:

  • Affirmation of 2019 guidance:
    • Projected FY 2019 revenue of $7-8 million
    • Projected FY 2019 cash burn of $3-3.5 million per month
    • Projected FY 2019 working capital of $2-3 million financed internally
  • Announcing more than one dozen customers for soybean meal and Calyno™ oil
  • Currently sold out of meal, with planned additional crush in July
  • Landus Cooperative represents future revenue opportunity on meal sales
  • Calyno™ oil is marketed through Sysco Foods, the previously announced broadline foodservice distributor
  • Grower planting progress of Calyxt High Oleic Soybean is in line with industry average

The presentation materials are available on www.calyxt.com/investors and a replay of the business presentation will be available on June 26, 2019.

About Calyxt
Calyxt is committed to making the food you love a healthier choice. The care we take extends beyond nutritional value. We partner with farmers and food companies to deliver traceable plant-based products developed to be healthier and more sustainable than their conventional counterparts. We use cutting edge plant breeding techniques to develop products that help improve diets by reducing bad fats, allergens and toxins. Today oil from our high oleic soybean plants has lower saturated fats than commodity soybean oil. We are also developing high fiber wheat designed to provide an excellent source of daily fiber when incorporated into wheat-based foods. We continuously pursue innovation to deliver good food that is good for you.


Calyxt is located in Roseville, MN, and is listed on the Nasdaq market (ticker: CLXT). For further information please visit our website at www.calyxt.com.

Calyxt®, Calyno™ and the corporate logo are trademarks owned by Calyxt, Inc.

Forward Looking Statements
This communication contains “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. In some cases, you can identify these statements by forward-looking words such as “may,” “might,” “will,” “should,” “expects,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “potential” or “continue,” the negative of these terms and other comparable terminology. These forward-looking statements, which are subject to risks, uncertainties and assumptions about us, may include projections of our future financial performance, our anticipated growth strategies and anticipated trends in our business. These statements are only predictions based on our current expectations and projections about future events. There are important factors that could cause our actual results, level of activity, performance or achievements to differ materially from the results, level of activity, performance or achievements expressed or implied by the forward-looking statements, including those factors discussed under the caption entitled “Risk Factors” in our Annual Report on Form 10-K, along with our other filings with the U.S. Securities and Exchange Commission. We do not assume any obligation to publicly provide revisions or updates to any forward-looking statements, whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws.

Contacts

Media
Trina Lundblad, Communications Director
Phone: +1 612-790-0514
email: trina.lundblad@calyxt.com

Investor Relations
Simon Harnest, VP Corporate Strategy and Finance
Phone: +1 646-385-9008
email: simon.harnest@calyxt.com

Exhibit 99.2